MEDGX | PREMX | MEDGX / PREMX | |
Total Expense Ratio | 0.81 | 0.93 | 87% |
Annual Report Gross Expense Ratio | 0.82 | 0.93 | 88% |
Fund Existence | 17 years | 31 years | - |
Gain YTD | 8.087 | 9.334 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.43B | 5.04B | 147% |
Annual Yield % from dividends | 5.67 | 5.84 | 97% |
Returns for 1 year | 7.79 | 9.25 | 84% |
Returns for 3 years | 31.05 | 35.11 | 88% |
Returns for 5 years | 11.41 | 11.30 | 101% |
Returns for 10 years | 48.62 | 41.86 | 116% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MLAAX | 10.81 | 0.10 | +0.93% |
NYLI Winslow Large Cap Growth Class A | |||
IJPTX | 15.11 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S2 | |||
GSXPX | 59.33 | N/A | N/A |
Goldman Sachs Small Cp Val Insghts P | |||
LPFAX | 6.65 | N/A | N/A |
ALPS Global Opportunity A | |||
PRDAX | 12.10 | N/A | N/A |
Principal Diversified Real Asset A |